Rgls stocktwits
Regulus Therapeutics (RGLS) has 1 split in our RGLS split history database. The split for RGLS took place on October 04, 2018. This was a 1 for 12 reverse split, meaning for each 12 shares of RGLS owned pre-split, the shareholder now owned 1 share. 4 Wall Street analysts have issued ratings and price targets for Regulus Therapeutics in the last 12 months. Their average twelve-month price target is $1.50, suggesting that the stock has a possible upside of 94.81%. The high price target for RGLS is $2.00 and the low price target for RGLS is $1.00.